SYNX News

SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT)

Silynxcom Receives a $1.1 Million Purchase Order for Tactical Systems from a Middle East Military Force

Silynxcom Reports Accumulated Orders Surpassing $1 Million in the Past Month for its Tactical Protection and Communication Solutions

Silynxcom Receives Approximately $100,000 Order for Elite Military Units in the Middle East

Silynxcom Receives Over $620,000 Tactical Systems Order from a Military Force in the Middle East

Syntax Data Announces Saidee™, Exclusive AI Agent and Portfolio Development Application

Silynxcom Wins Government Tender Valued at Approximately $400,000 for Tactical Protective Systems for a Military Force in Asia

Silynxcom Secures Follow-On Order from Asia-Pacific Special Forces, Reinforcing Trust in Advanced In-Ear Systems

Silynxcom Announces New Orders from Fire and Police Departments in Europe

Silynxcom Announces Successful Field Evaluation of CLARUS II by Elite NATO Counter-Terrorism Unit